English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase Journal article
Shen, Junyi, Hu, Rong, Lin, Anqi, Jiang, Aimin, Tang, Bufu, Liu, Zaoqu, Cheng, Quan, Miao, Kai, Zhang, Jian, Luo, Peng. Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase[J]. eClinicalMedicine, 2024, 73, 102684.
Authors:  Shen, Junyi;  Hu, Rong;  Lin, Anqi;  Jiang, Aimin;  Tang, Bufu; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5 | Submit date：2024/07/04
Car-t  Faers  Myelodysplastic Syndromes  Second Primary Malignancy  T-cell Lymphoma  Vigibase  
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells Journal article
He, Tianzhen, Chen, Yibo, Yang, De, Islam, Md Sahidul, Chou, Chon Kit, Liu, Jiarui, Faustman, Denise L., Oppenheim, Joost J., Chen, Xin*. TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells[J]. Cellular Oncology, 2022, 46(1), 167-177.
Authors:  He, Tianzhen;  Chen, Yibo;  Yang, De;  Islam, Md Sahidul;  Chou, Chon Kit; et al.
Favorite | TC[WOS]:7 TC[Scopus]:6  IF:4.9/5.2 | Submit date：2023/01/30
cd4+foxp3+ Regulatory t Cells (Tregs)  Cell Death  Lymphoma  Tnfr2  Tnfr2 Antagonistic Antibody